Literature DB >> 20688891

The effect of airflow limitation on the cause of death in patients with COPD.

Inmaculada Alfageme1, Nuria Reyes, Mercedes Merino, Angela Reina, Javier Gallego, Jorge Lima, Zulema Palacios.   

Abstract

COPD is characterized by airflow limitation that is usually progressive. The present study investigated the cause of death and the effect of airflow limitation on all-cause mortality in COPD patients. A prospective cohort of 600 COPD patients were followed for 3 years. Patients in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 2 (32.7%), GOLD 3 (48.1%), or GOLD 4 (19.1%). Overall, 117 patients died (19.6%). Deaths were due to respiratory failure (29%), cardiovascular disease (25.6%), cancer (17.9%), infection (11%), gastrointestinal disease (9.4%), and other causes (6.7%). According to the Cox regression analysis, the following independent factors were related to mortality: age (years), hazards ratio (HR) 1.046 (confidence interval [CI] 95% 1.021, 1.072); current smoking status, HR 1.535 (CI 95% 1.003, 2.350); cancer, HR 7.172 (CI 95% 4.515, 11.395); cardiovascular disease, HR 2.623 (CI 95% 1.821, 3.778); severe airflow limitation (GOLD 4), HR 2.378 (CI 95% 1.605, 3.525); and highest quartile of acute exacerbations, HR 1.852 (CI 95% 1.236, 2.775). The present study shows that severe airflow limitation, current smoking status, the presence of cardiovascular disease, cancer, and a high frequency of acute exacerbations have an independent negative impact on the prognosis of COPD patients.

Entities:  

Mesh:

Year:  2010        PMID: 20688891     DOI: 10.1177/1479972310368692

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  8 in total

Review 1.  Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.

Authors:  Yangxue Li; Yang Lu; Zhuo Zhao; Junnan Wang; Jianxin Li; Weiming Wang; Shumei Li; Lei Song
Journal:  J Res Med Sci       Date:  2016-03-15       Impact factor: 1.852

2.  Pulmonary complications after abdominal surgery in patients with mild-to-moderate chronic obstructive pulmonary disease.

Authors:  Tae Hoon Kim; Jae Seung Lee; Sei Won Lee; Yeon-Mok Oh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-09

3.  Prognostic assessment in COPD without lung function: the B-AE-D indices.

Authors:  Lucas Boeck; Joan B Soriano; Marjolein Brusse-Keizer; Francesco Blasi; Konstantinos Kostikas; Wim Boersma; Branislava Milenkovic; Renaud Louis; Alicia Lacoma; Remco Djamin; Joachim Aerts; Antoni Torres; Gernot Rohde; Tobias Welte; Pablo Martinez-Camblor; Janko Rakic; Andreas Scherr; Michael Koller; Job van der Palen; Jose M Marin; Inmaculada Alfageme; Pere Almagro; Ciro Casanova; Cristobal Esteban; Juan J Soler-Cataluña; Juan P de-Torres; Marc Miravitlles; Bartolome R Celli; Michael Tamm; Daiana Stolz
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

Review 4.  Animal models of emphysema.

Authors:  Gui-Bin Liang; Zhi-Hui He
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

5.  What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?

Authors:  Çağla Koç; Füsun Şahin
Journal:  Medicina (Kaunas)       Date:  2022-01-21       Impact factor: 2.430

6.  Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study.

Authors:  Pere Almagro; Pablo Martinez-Camblor; Joan B Soriano; Jose M Marin; Inmaculada Alfageme; Ciro Casanova; Cristobal Esteban; Juan J Soler-Cataluña; Juan P de-Torres; Bartolome R Celli; Marc Miravitlles
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

7.  Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD.

Authors:  Jukka Koskela; Maritta Kilpeläinen; Henna Kupiainen; Witold Mazur; Harri Sintonen; Marike Boezen; Ari Lindqvist; Dirkje Postma; Tarja Laitinen
Journal:  BMC Pulm Med       Date:  2014-06-19       Impact factor: 3.317

8.  FEV1 and total Cardiovascular mortality and morbidity over an 18 years follow-up Population-Based Prospective EPIC-NORFOLK Study.

Authors:  Siew-Mooi Ching; Yook-Chin Chia; Marleen A H Lentjes; Robert Luben; Nicholas Wareham; Kay-Tee Khaw
Journal:  BMC Public Health       Date:  2019-05-03       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.